Certa Dose, Inc.
Michael Sheehan | 7/12/2021 | Bankruptcy
Patent Backed Bankruptcy Report
Company Background:
Certa Dose, Inc. designs and develops syringes for eliminating pediatric medication dosing errors. It offers color coded syringes to determine the medicine doses for pediatrics. The company’s syringes are used by parents, nurses, doctors, and paramedics at various points of care, including pre-hospitals, hospitals, and homes. Certa Dose, Inc. was founded in 2013 and is based in Denver, Colorado with operations in Indianapolis, Indiana.
Address
Ownership
Industry
2590 Welton Street, Suite 200
Denver, CO 80205
Private
Medical Equipment
Chapter Type | Case Number | Assets | Liabilities | Industry/Description |
11 | 1:2021bk11045 | 10 Mil – 50 Mil | 50 Mil – 100 Mil | Medical Equipment |
|
Portfolio Valuation Range |
Asset Valuation Range |
Total Assets Valuation Range |
Liability Range |
Leverage Ratio Range |
|
$25,000 – $100,000 |
$5 Mil – $50 Mil |
$5.025 Mil – $50.1 Mil |
$25 Mil – $75 Mil |
0.067 – 2.004 |
Patent Portfolio Breakdown
2 Active US Patents
Featured Asset
Abstract:
Aspects
of the present disclosure disclose a system and method for delivering for
administering radiation to a patient. The method may include associating the
patient with one of a plurality of coded dosage zones wherein each of the
plurality of coded dosage zones corresponds to one or more values of a physical
characteristic. The method may further include correlating the one of the
plurality of coded dosage zones to a dose of radiation and then applying the
dose of radiation to the patient.
Claim 1:
A method of administering radiation to a patient, the method comprising:
receiving, at a processor associated with a radiation device, information indicating that a patient is associated with a coded region included among a plurality of coded regions wherein each of the plurality of coded regions corresponds to one or more values of a physical characteristic wherein the processor determines a patient size;
receiving, at the processor, a radiation location for the patient;
determining, at the processor and based on the patient size, a safe range of radiation for the patient;
correlating, at the processor, the coded region and the radiation location with a dose of radiation; and
applying the dose of radiation to the patient at the radiation location.
.
Michael is interested in how companies value their IP. These reports are focused primarily on the value IP brings to Companies after filing for bankruptcy.
